Significant correlation shown between blood levels and symptom relief; TH104 was well tolerated with no unexpected ...

Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...

British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

The analysis revealed that 81% of individuals treated with Livdelzi achieved a composite biochemical response.

The London-based pharmaceutical company said that in cholestatic pruritus, also known as relentless itch, in primary biliary cholangitis, an autoimmune disease known as PBC, linerixibat showed a ...

Tharimmune, Inc. (NASDAQ:THAR) shares initially traded higher on Monday, but have since reversed after the company presented ...

RTY-694 increased protein levels and function of ABCB4 and BSEP in primary hepatocytes, two transporters that play a key role in bile composition ...

This includes building on the momentum from the U.S. launch of Livdelzi for primary biliary cholangitis and preparing for the ...

Some of the drugs in the third phase are gepotidacin, which will be used to treat urogenital gonorrhoea, bepirovirsen ...

In human patients with primary biliary cholangitis and primary sclerosing cholangitis, we found JAM-A upregulation in cholangiocytes, suggesting a conserved mechanism of barrier protection in the ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

UNRWA, the main U.N. agency aiding Palestinians, said its drivers were forced to unload supplies at gunpoint, in what it called one of the worst such incidents of the war. By Hiba Yazbek The ...